OncoSenX
Eric Garcia is the Chief Operating Officer and Treasurer of OncoSenX. He has responsibility for the company’s finances and business operations. Mr. Garcia also helped start Oisin Biotechnologies, serving as its COO. Prior to Oisin Biotechnologies Mr. Garcia was the Chief Financial Officer for the immunotherapy biotech, Immusoft Corporation. Outside biotechnology, Mr. Garcia has worked in banking, financial management and public policy.
OncoSenX
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.